Halting Bangladesh's Doubling Diabetes Curve: A DGHS-Led Primary-Care Detection and Control Mandate

Diagnosis

Adult diabetes prevalence in Bangladesh now sits at roughly 13% per the IDF Atlas, and it has doubled since 2011. That trajectory is the defining feature of the problem: this is not a stable burden to be managed at current levels, but a rising tide that is on course to keep climbing unless the underlying drivers are interrupted. A doubling in roughly a decade means the cohort entering middle age today faces materially higher lifetime risk than the cohort before it, and the downstream costs (kidney failure, cardiovascular disease, amputation, blindness) compound years after onset. This is a tier-1, structural health problem: the regime, not a one-off shock, is what must change. The Directorate General of Health Services (DGHS) is the lead responsible body, with the Department of Public Health Engineering as a supporting actor on the environmental and water-quality side. The strategic implication is that detection and continuity of care, not just treatment of those who present in crisis, are where leverage lies. A large share of the doubling is concentrated in people who do not yet know they have the disease, which makes the primary-care layer the decisive battleground.

Recommended actions

1. Mandate opportunistic screening at every Upazila Health Complex and Community Clinic.

• Owner: DGHS.
• Mechanism: a DGHS circular requiring random blood glucose screening for every adult attending any public facility for any reason, logged in a standard register, with abnormal results triggered into a follow-up pathway.
• Observable signal: rising count of newly registered diabetic and pre-diabetic patients per facility per month, narrowing the gap between estimated and diagnosed prevalence.

1. Stand up a continuity-of-care register so the diagnosed do not fall out of treatment.

• Owner: DGHS.
• Mechanism: a non-communicable disease (NCD) corner in every Upazila Health Complex with a named focal officer, a patient-held card, and a recall list that flags anyone who misses a quarterly visit.
• Observable signal: share of registered patients with a documented follow-up visit within the quarter trending up, and dropout rate trending down.

1. Guarantee uninterrupted supply of essential glucose-lowering medicines at the primary level.

• Owner: DGHS.
• Mechanism: add metformin and the core oral agents to the standing essential-drug allocation for Community Clinics and Upazila Health Complexes via the central procurement and distribution line, with a stock-out alert in the existing logistics reporting.
• Observable signal: facility-level stock-out days for first-line medicines falling toward zero on the monthly logistics dashboard.

1. Embed prevention messaging and supporting environmental action at community level.

• Owner: DGHS, with the Department of Public Health Engineering on the supporting side.
• Mechanism: structured counseling at every screening contact plus DPHE coordination on safe water and sanitation at the same facilities, so the prevention message is reinforced where people already come for care.
• Observable signal: counseling sessions recorded per screened patient, and patient-reported recall of risk-reduction advice rising over successive surveys.

Sequencing (first 12 months)

Start with the screening circular (action 1) because it is the cheapest to issue and it surfaces the hidden caseload that everything else depends on. Surfacing that caseload immediately makes the case for the continuity register (action 2), which has no value until there are diagnosed patients to retain. Run the medicine-supply fix (action 3) in parallel from month one, because diagnosing people without then being able to treat them erodes trust and wastes the screening effort. Prevention and DPHE coordination (action 4) layer on once the contact points are already busy, so the messaging rides on traffic that already exists rather than requiring new infrastructure.

Risks and constraints

The binding constraint is recurrent fiscal capacity, not policy design: screening that finds patients creates a permanent treatment and medicine bill that must be funded year after year, and a doubling caseload means that bill grows. Underfunding the medicine line (action 3) is the most dangerous failure mode, because it converts a credible programme into a cynical one. The second constraint is primary-care workforce and time: NCD follow-up competes with existing maternal, child, and infectious-disease workloads at the same clinics. Without a named focal officer and protected register, screening volume will not translate into sustained control.

Bottom line

A diabetes burden near 13% that has doubled since 2011 is a regime problem, and the only durable response is to move detection and continuity of care into the primary-care layer that DGHS already runs. Issue the screening circular first, fund the medicine line in parallel, and judge success by how fast the diagnosed-to-estimated gap closes and stock-out days fall to zero.